Healthcare Global Enterprises Limited has informed the Exchange that Board of Directors at its meeting held on February 24, 2026, has decided to issue equity shares on rights basis in the ratio of 1: 17 (1 Rights Equity Share for every 17 fully paid-up equity shares), to eligible equity shareholders, held as on the Record Date being March 02, 2026 at an Issue Price of Rs. 512 per share.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Healthcare Global Enterprises (HCG) has approved a rights issue of equity shares at a ratio of 1 new share for every 17 existing shares held. The issue price is fixed at ₹512 per share (including a premium of ₹502 over the face value of ₹10). The total issue size is approximately ₹424.68 crores, comprising around 82.94 lakh new shares. The record date to determine eligible shareholders is March 2, 2026, and the issue opens on March 11, 2026, and closes on March 25, 2026. If fully subscribed, the company's outstanding equity shares will increase from about 14.1 crore to 14.93 crore. The new shares are expected to list on the exchanges by April 1, 2026.
Existing shareholders will need to decide whether to subscribe to their entitlement or let it lapse, with the potential for dilution if they do not participate. The company will raise around ₹425 crores to fund its growth or reduce debt, which could be positive for long-term value if deployed effectively.